Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model
Conduit Pharmaceuticals partners with Charles River to evaluate the efficacy of its lead programme in a pre-clinical lupus model, utilizing ...
International Union for Conservation of Nature6d
Launch of the Regional Initiative for Water and Environment in the transboundary basin of the Mono River (RIWE-Mono)
The GEF-funded RIWE-Mono Project was launched in Grand Popo, Benin, on 30 January 2025, with the objective to ensure the sustainable development and ecological resilience of the Mono River Basin ...
BMJ5d
B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial
Objective Randomised trials of type I anti-CD20 antibodies rituximab and ocrelizumab failed to show benefit in proliferative lupus nephritis (LN). We compared obinutuzumab, a humanised type II ...
Medscape4d
Evidence-based Complementary and Alternative Medicine: eCAM
Mission Statement: Evidence-based Complementary and Alternative Medicine (eCAM) is an international, peer-reviewed journal that seeks to understand the sources and to encourage rigorous research ...